Big Infrastructure Investments Could Prove Costly to Taxpayers, Lucrative to Fraudsters
Whistleblowers have a long history of reporting and prosecuting all types of infrastructure fraud through the False Claims Act.
New DOJ Statistics Spotlight the Role of Whistleblowers in Exposing Pandemic Health Care Fraud
Over 58% of all actual recoveries—amounting to $1.6 billion—came from whistleblower-initiated, or qui tam, actions.
Like the Omicron Variant, COVID-19 Fraud Continues to Run Rampant
As we approach the third year of the COVID-19 pandemic, it’s about time we check in on the fraud against the government relief programs.
The Whistleblower Interview: What do you need to know?
If you are a whistleblower who has filed a case under the False Claims Act, this is your moment.
How Telehealth Became a Big Target for Fraudsters
Prior to the pandemic, Medicare imposed strict limitations on when telehealth services were covered.
Pharmaceutical Company Payments to Co-Pay Foundations Merit Continued Scrutiny
Employees of pharmaceutical companies and co-pay foundations are particularly well-situated to observe and identify behavior that is not purely charitable.
The FIRREA Whistleblower Statute: A failure to adequately incentivize whistleblowing
Congress recognized that DOJ would need help in enforcing FIRREA – namely, help from corporate insiders who could blow the whistle on fraudulent schemes.
Are Whistleblowers Protected From Blacklisting?
Corporations often “blacklist” former employees as retaliation for whistleblowing regarding illegal activity.
TAF Offers Suggestions to Strengthen the SEC Whistleblower Program
Given the Chairman Gensler's support of whistleblowers, TAF is confident that these recommendations will be given every consideration.
STATEMENT: Anti-Fraud Senators Vote to Strengthen the Government's Primary Fraud-Fighting Tool
“Today, the vast majority of the Senate Judiciary Committee decided to protect taxpayer dollars from fraud.”
